|
159
|
838
|
6whtA |
Glun1b-glun2b nmda receptor in active conformation at 4.4 angstrom resolution |
|
150
|
838
|
6whuA |
Glun1b-glun2b nmda receptor in complex with sdz 220-040 and l689,560, class 1 |
|
149
|
811
|
6whuB |
Glun1b-glun2b nmda receptor in complex with sdz 220-040 and l689,560, class 1 |
|
150
|
811
|
6whvB |
Glun1b-glun2b nmda receptor in complex with sdz 220-040 and l689,560, class 2 |
|
142
|
838
|
6whvA |
Glun1b-glun2b nmda receptor in complex with sdz 220-040 and l689,560, class 2 |
|
148
|
805
|
6whtB |
Glun1b-glun2b nmda receptor in active conformation at 4.4 angstrom resolution |
|
147
|
838
|
6wi0A |
Glun1b-glun2b nmda receptor in complex with glun1 antagonist l689,560, class 2 |
|
159
|
809
|
6wi0B |
Glun1b-glun2b nmda receptor in complex with glun1 antagonist l689,560, class 2 |
|
80
|
283
|
6usuA |
Crystal structure of glun1/glun2a ligand-binding domain in complex with l689,560 and glutamate |
|
78
|
285
|
6usvA |
Crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and sdz 220-040 |
|
87
|
279
|
6usuB |
Crystal structure of glun1/glun2a ligand-binding domain in complex with l689,560 and glutamate |
|
83
|
280
|
6usvB |
Crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and sdz 220-040 |
|
79
|
285
|
6oveA |
Crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 4-propylphenyl-acepc |
|
78
|
283
|
6ovdA |
Crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 3-ethylphenyl-acepc |
|
85
|
280
|
6oveB |
Crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 4-propylphenyl-acepc |
|
82
|
281
|
6ovdB |
Crystal structure of glun1/glun2a nmda receptor agonist binding domains with glycine and antagonist, 3-ethylphenyl-acepc |
|
84
|
280
|
6uzwB |
Crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and ubp791 |
|
79
|
288
|
6uzrA |
Crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and homoquinolinic acid |
|
86
|
280
|
6uzgB |
Crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and homoquinolinic acid |
|
81
|
280
|
6uzxB |
Crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and ubp791 |
|
87
|
280
|
6uzrB |
Crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and homoquinolinic acid |
|
89
|
280
|
6uz6B |
Crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and glutamate |
|
84
|
287
|
6uzgA |
Crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and homoquinolinic acid |
|
83
|
287
|
6uz6A |
Crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and glutamate |
|
83
|
287
|
6uzxA |
Crystal structure of glun1/glun2a-4m mutant ligand-binding domain in complex with glycine and ubp791 |
|
81
|
285
|
6uzwA |
Crystal structure of glun1/glun2a ligand-binding domain in complex with glycine and ubp791 |
|
171
|
804
|
6mmtD |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
158
|
814
|
6mmxA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
175
|
804
|
6mmuB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
171
|
814
|
6mmwA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
178
|
804
|
6mmmB |
Diheteromeric nmda receptor glun1/glun2a in the 'extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
177
|
804
|
6mmuD |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
173
|
804
|
6mmaB |
Diheteromeric nmda receptor glun1/glun2a in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
165
|
804
|
6mmlB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
157
|
814
|
6mmmA |
Diheteromeric nmda receptor glun1/glun2a in the 'extended-1' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
169
|
804
|
6mmtB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
169
|
804
|
6mmrB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar edta, and at ph 7.4 |
|
162
|
804
|
6mmxB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the 'extended' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
165
|
814
|
6mmlA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
176
|
804
|
6mm9B |
Diheteromeric nmda receptor glun1/glun2a in the '1-knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 6.1 |
|
166
|
814
|
6mmrA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, 3 millimolar edta, and at ph 7.4 |
|
160
|
814
|
6mmiA |
Diheteromeric nmda receptor glun1/glun2a in the 'splayed-open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
167
|
814
|
6mmpA |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar edta, and at ph 8.0 |
|
138
|
767
|
6mmvD |
Triheteromeric nmda receptor glun1/glun2a/glun2a* extracellular domain in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
162
|
804
|
6mmsB |
Triheteromeric nmda receptor glun1/glun2a/glun2a* in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar edta, and at ph 7.4 |
|
161
|
804
|
6mmpB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 0.1 millimolar edta, and at ph 8.0 |
|
152
|
804
|
6mmjB |
Diheteromeric nmda receptor glun1/glun2a in the 'super-splayed' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
160
|
804
|
6mmiB |
Diheteromeric nmda receptor glun1/glun2a in the 'splayed-open' conformation, in complex with glycine and glutamate, in the presence of 1 millimolar zinc chloride, and at ph 7.4 |
|
130
|
773
|
6mmvA |
Triheteromeric nmda receptor glun1/glun2a/glun2a* extracellular domain in the '2-knuckle-asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 7.4 |
|
153
|
804
|
6mmnB |
Diheteromeric nmda receptor glun1/glun2a in the '2-knuckle-symmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at ph 8.0 |
